3/27/2019 12:00 PM Eastern
3/27/2019 1:00 PM Eastern
For life sciences companies, the rules for conducting day-to-day international operations and transaction tax planning have changed dramatically as a result of recent U.S. tax reform as well as certain global tax developments. Whether it relates to intangible or fixed assets, intellectual property, where and how to best manage cash and reinvestments, acquiring international targets, or establishing operations abroad, U.S. tax reform presents a multitude of new issues for life sciences companies to consider. During this webinar, we’ll explore how these issues are impacting transaction, compliance, and provision planning for these companies. We will also touch on how the new regulations and guidance have raised more questions and reporting complexities.
During this webinar, we’ll explore how leading organizations are staying ahead of the curve with new international tax-related regulations and added compliance requirements, how and where they are investing time and resources to maximize returns, and whether it makes sense to migrate capital, intangibles, and certain aspects of the supply chain back to the United States.
By participating in this session, you should be able to:
This session is recommended for 1.0 hour of CPE credit.
Additional CPE information
Advance preparation: None
Program level: Basic
Field of study: Tax
Delivery method: Group internet
There is no registration fee for this webinar; therefore, there is no cancellation fee. Note: All participants MUST be logged into the webinar INDIVIDUALLY to receive CPE credit.
For additional information please contact Dana Roxbury.